Zuoli Pharmaceutical: Announcement on the Change of Signed Certified Public Accountants and Quality Control Reviewers
Zuoli Pharmaceutical: Report by Guojin Securities Co., Ltd. on the 2024 continuous supervision and training situation of Zhejiang Zuoli Pharmaceutical Co., Ltd.
Zuoli Pharmaceutical: Guojin Securities Co., Ltd.\'s 2024 regular on-site inspection report on Zhejiang Zuoli Pharmaceutical Co., Ltd.
Zuoli Pharmaceuticals: Investor Relations Activity Record Form for November 26, 2024
Zuoli Pharmaceutical: Record of Investor Relations Activities from November 19, 2024 to November 20, 2024
Zuoli Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Zuoli Pharmaceutical: Self-inspection report on the 2024 Restricted Stock Incentive Plan insider\'s stock trading situation
Zuoli Pharmaceutical: Announcement on signing a strategic cooperation framework agreement with Lingyi (Hangzhou) Biotechnology Co., Ltd.
Zuoli Pharmaceutical: Legal Opinion of Shanghai Oriental Huayin Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Zhejiang Zuoli Pharmaceutical Co., Ltd.
Zuli Pharmaceuticals: 2024 Employee Stock Ownership Plan
Zuoli Pharmaceutical: Explanation of the Supervisory Committee\'s disclosure and verification opinions on the 2024 Restricted Stock Incentive Plan incentive list
Zuoli Pharmaceutical: Record of Investor Relations Activities from October 28, 2024 to October 29, 2024
Zuli Pharmaceuticals: 2024 Employee Stock Ownership Plan (Draft) Summary
Zuoli Pharmaceutical: Self-inspection Form for Equity Incentive Plans for GEM Listed Companies
Zuli Pharmaceutical: 2024 Employee Stock Ownership Plan (Draft)
Zuoli Pharmaceutical: Announcement of Resolutions of the Third Meeting of the Eighth Board of Directors
Zuoli Pharmaceutical: 2024 Restricted Stock Incentive Plan Implementation Assessment Management Measures
Zuoli Pharmaceutical: Announcement on Open Call for Voting Rights for Independent Directors
Zuoli Pharmaceutical: Announcement on the Notice of Convening the First Extraordinary General Meeting of Shareholders in 2024
Zuli Pharmaceuticals: 2024 Restricted Stock Incentive Plan (Draft)